Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text

Medicine, Clinical Sciences, Oncology +12

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 8K citations · Full text

Life Sciences, Immunology, Oncology +17

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Tammy F. Chu, Maria A. Rupnick, Risto Kerkelä et al. · The Lancet · 2007 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text

Medicine, Oncology, Pharmacology +11

Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

Dingcheng Gao, Daniel J. Nolan, Albert S. Mellick et al. · Science · 2008 · 635 citations · Full text

Medicine, Cancer Biology, Oncology +17